Citations with the tag: HIV (Viruses)
Results 51 - 100
- Research on treating HIV in minorities.
// FDA Consumer; May91, Vol. 25 Issue 4, p7
Announces that a program to encourage research on therapies to treat HIV infection in minorities has been started by the National Institute of Allergy and Infectious Diseases (NIAID). Awarding of grants; Figures of minorities with HIV infections and AIDS.
- Guidelines set for HIV-infected health workers.
// FDA Consumer; Oct91, Vol. 25 Issue 8, p7
Comments on new guidelines concerning HIV-infected health workers issued by the US Department of Health and Human Services. Physicians, dentists, and other health-care workers who are infected with HIV, the virus that causes AIDS, should not perform `exposure-prone' medical procedures unless...
- High schoolers' practices risky business.
// FDA Consumer; Jul/Aug92, Vol. 26 Issue 6, p7
Reports that more than half of high school students in the United States put themselves at risk for contracting HIV, the virus that causes AIDS, according to a study recently published by the national Centers for Disease Control. The 1990 CDC Youth Risk Behavior Survey, published in the April...
- The AIDS file.
Davis, L. // Health (Time Inc. Health); Feb92, Vol. 6 Issue 1, p20
Discusses how it's been difficult for researchers to come up with a reliable estimate of the rate of HIV infection in teens, and shows many ways they are attempting to do so. Worrisome implications; Findings; `Incomplete' infections; More.
- Vertical transmission of HIV in New York State: A basis for...
Charbonneau, Tina T.; Wade, Nancy A. // AIDS Patient Care & STDs; Aug97, Vol. 11 Issue 4, p227
Highlights a three year prospective study of vertical transmission which was conducted on infants of human immunodeficiency virus-infected (HIV) mothers. Reference to fifty-six infants which have laboratory and clinical evidence of HIV infection; Details of the study.
- Genital dermatology in the HIV-infected patient.
Helton, Jennifer L. // AIDS Patient Care & STDs; Aug97, Vol. 11 Issue 4, p237
Presents a summary of common genital dermatologic conditions seen in the human immunodeficiency virus-infected (HIV) patient, which often differs in clinical presentation from that seen in the normal host, with emphasis on diagnosis and treatment. Diagnosis and symptoms of the herpes simplex...
- Programs to reduce HIV risk behaviors among gay men hinge on social networks.
Makulowich, Gail S. // AIDS Patient Care & STDs; Aug97, Vol. 11 Issue 4, p297
Focuses on the programs used to reduce Human Indeficiency Virus (HIV) risk behaviors among gay men. Impact of these programs on social networks; Reference made to the figures of certain states in the United States; Details on the role of ethnicity in this procedure; Information on the program...
- Mystery syndrome.
Makulowich, Gail S. // New Scientist; 10/3/92, Vol. 136 Issue 1841, p11
Reports that a search conducted by the WHO in developing countries has so far revealed fewer than 20 cases of the unexplained HIV-negative immune deficiency syndrome. Number of confirmed cases in the United States has risen to 47, up from 30 in August; Worldwide there are fewer than 100;...
- INDIANA: Health officials urge blacks to be tested for AIDS.
Makulowich, Gail S. // Gay & Lesbian Times; 11/12/2009, Issue 1142, p18
The article reports on the initiation of a Statewide HIV Awareness Program by the Department of Health, the Indiana Family and Social Services Administration and the Indiana Minority Health Coalition in November 2009 in Indianapolis, Indiana.
- HIV destroys cells long before onset of AIDS.
Makulowich, Gail S. // New Scientist; 11/7/92, Vol. 136 Issue 1846, p7
Reports on research by Anthony Fauci, head of the United State government's AIDS research efforts at the National Institutes of Health, who has found that the AIDS virus invades and destroys key components of the immune system after a person has been infected. Clues from a mouse with a human...
- AIDS exports.
Makulowich, Gail S. // New Scientist; 11/7/92, Vol. 136 Issue 1846, p11
Reveals that the Institut Merieux, a subsidiary of the French chemicals firm Rhone-Poulenc, has announced that in 1985 it exported blood products that were not heat-treated to destroy HIV. About 3.2 million units of Factor 8 were exported; Countries that received the blood products;...
Kay, Thelma // Asia-Pacific Population Journal; Dec2007, Vol. 22 Issue 3, p2
An introduction to the journal is presented in which the editor discusses an article on the demographic impact of HIV/AIDS in Papua New Guinea, population issues, and reproductive health programmes.
- NYC new HIV cases 3 times national rate.
Kay, Thelma // Gay & Lesbian Times; 9/4/2008, Issue 1080, p23
The article discusses the data from city health department, which indicates that New York City residents are contracting HIV at three times the national rate.
- Further fears of HIV in India.
Jayaraman, K.S. // Nature; 2/9/1989, Vol. 337 Issue 6207, p496
Reports on an investigation launched in India after the chance discovery of HIV (human immunodeficiency virus) antibodies in a widely used product derived from donors' blood. Other HIV scares.
- High levels of unintegrated HIV-1 DNA in brain tissue of AIDS dementia patients.
Pang, S.; Koyanagi, Y. // Nature; 1/4/1990, Vol. 343 Issue 6253, p85
Modifies the PCR method in order to study the amount and form of HIV-1 DNA primary tissue of AIDS patients. Methods; Results; Discussion.
- Inhibition of HIV-1 protease in infected T-lymphocytes by synthetic peptide analogues.
Meek, T.D.; Lambert, D.M. // Nature; 1/4/1990, Vol. 343 Issue 6253, p90
Demonstrates that synthetic peptide analogues, which are potent inhibitors of purified HIV-1 protease, inhibit the processing of the viral polyproteins in cultures of HIV-1-infected T lymphocytes and attenuate viral infectivity. Methods; Results; Discussion.
- Serine phosphorylation-independent down regulation of cell-surface CD4 by nef.
Garcia, J.V.; Miller, A.D. // Nature; 4/11/1991, Vol. 350 Issue 6318, p508
Expresses the `nef' gene of human immunodeficiency virus type 1 (HIV-1) in three lymphocytic cell lines expressing CD4 using a Moloney murine leukemia virus-based retroviral vector. Experimental methods; Results; Discussion.
- Do antibodies enhance the infection of cells by HIV?
Bolognesi, D.P. // Nature; 8/10/1989, Vol. 340 Issue 6233, p431
Examines the mechanisms by which human immunodeficiency virus (HIV) can enter cells other than by the conventional mechanisms of attachment of HIV to CD4. Process.
- Biological properties of a CD4 immunoadhesin.
Byrn, R.A.; Mordenti, J. // Nature; 4/12/1990, Vol. 344 Issue 6267, p667
Demonstrates that a CD4 immunoadhesin can mediate antibody-dependent cell-mediated cytotoxicity towards human immunodeficiency virus (HIV)-infected cells. Methods; Results; Discussion.
- Prevention of HIV-1 glycoprotein transport by soluble CD4 retained in the endoplasmic reticulum.
Buonocore, L.; Rose, J.K. // Nature; 6/14/1990, Vol. 345 Issue 6276, p625
Demonstrates that expression of a soluble CD4 molecule, mutated to contain a specific retention signal for the endoplasmic reticulum, blocks secretion of gp120 and surface expression of gp120/41, but does not interfere with transport of wild-typeCD4.
- Activation of transcription by HIV-1 Tat protein tethered to nascent RNA through another protein.
Southgate, C.; Zapp, M.L. // Nature; 6/14/1990, Vol. 345 Issue 6276, p640
Presents research reporting that HIV-1 Tat protein can activate transcription when bound to nascent RNA through the RNA-binding domain of another HIV-1 protein, Rev. Methods; Results; Discussion.
- Blocking of Tat-dependent HIV-1 RNA modification by an inhibitor of RNA polymerase II processivity.
Braddock, M.; Thorburn, A.M. // Nature; 4/4/1991, Vol. 350 Issue 6317, p439
Demonstrates that Tat activation of its target RNA in the nucleus involves a Tat-dependent covalent modification. Also finds that the nucleoside analogue 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole blocks this Tat-dependent modification.
- Humoral and cell-mediated immune responses to live recombinant BCG-HIV vaccines.
Aldovini, A.; Young, R.A. // Nature; 6/6/1991, Vol. 351 Issue 6326, p479
Reports that a variety of human immunodeficiency virus (HIV) type 1 polypeptides can be expressed in `Mycobacterium bovis' bacillus Calmette-Guerin (BCG) recombinants under the control of mycobacterial hsp70 promoter. Foreign polypeptides produced in BCG can induce antibody and T-cell responses.
- The spread of HIV-1 in Africa: Sexual contact patterns and the predicted demographic impact of AIDS.
Anderson, R.; May, R.M. // Nature; 8/15/1991, Vol. 352 Issue 6336, p581
Examines the spread of the human immunodeficiency virus type 1 (HIV-1) in Africa. Epidemiology in Africa; Epidemiological parameters; Sexual behavior; Mathematical models; Discussion.
- HIV enhancer activity perpetuated by NF-kappa B induction on infection of monocytes.
Bachelerie, F.; Alcamo, J. // Nature; 4/25/1991, Vol. 350 Issue 6320, p709
Demonstrates that chronic human immunodeficiency virus (HIV) infection results in both induction of a nuclear factor with antigenic properties indistinguishable from those of NF-kappa B and permanently increased HIV enhancer activity. This phenomenon is associated with HIV replication and may...
- Human infection by genetically diverse SIVsm-related HIV-2 in West Africa.
Gao, Feng; Yue, Ling // Nature; 8/6/1992, Vol. 358 Issue 6386, p495
Relates that our understanding of the biology and origins of HIV-2 derives from studies of cultured isolates from urban populations experiencing epidemic infection and disease. Tests the hypothesis that such isolates might represent only a subset of a larger, more genetically diverse group of...
- Research presents hope for stopping HIV.
Gao, Feng; Yue, Ling // Modern Healthcare; 6/24/96, Vol. 26 Issue 26, p88
Reports on the optimism of researchers that the HIV virus can be eradicated. Discussion of clinical trials demonstrating viral suppression at a conference held in June 1996; Factors for researchers' optimism.
Gao, Feng; Yue, Ling // Advocate; 12/12/95, Issue 696, p39
Presents advice on how actively HIV reproduces and the chances of developing AIDS. Design of tests that measure the amount of virus being produced by HIV-infected cells.
- Court gives virus equal rights.
Gao, Feng; Yue, Ling // Human Events; 07/10/98, Vol. 54 Issue 26, p1
Reports on the court case Bragdon v. Abbott in the Supreme Court of the United States, in which a dentist was charged with violating the rights of a human immunodeficency virus (HIV) patient. Circumstances surrounding the case; Comments from Sidney Abbott, patient; Reference to the Americans...
- AIDS and endocrinology.
Laurence, Jeffrey // AIDS Patient Care & STDs; Oct97, Vol. 11 Issue 5, p317
Editorial. Presents information on the condition of some people after finding out that they are human immunodeficiency virus (HIV) positive. Comments from Doctor Anthony Fauci, director of the National Institute of Allergy and Immunology; Information on some complications of some recognized...
- International AIDS society, USA panel-updates antireoviral therapy for 1997.
Laurence, Jeffrey // AIDS Patient Care & STDs; Oct97, Vol. 11 Issue 5, p371
Reports on a study of the upgrade of a pathogenesis of human immunodeficiency virus (HIV) and the impact of the antiretroviral drug. Methodology used in the study; Results of the study; How HIV RNA has contributed in plasma; Discussion of study results.
- Priority on HIV.
Laurence, Jeffrey // Nature; 11/30/1989, Vol. 342 Issue 6249, p462
Opinion. Discusses a report in the `Chicago Tribune' by journalist John Crewdson concerning who first discovered the virus responsible for AIDS. Robert Gallo of the United States has been given too much credit and French researcher Montagnier too little credit. Report resurrects the...
- Is there a `successful' immune response to HIV?
Brown, Phyllida // New Scientist; 7/4/92, Vol. 135 Issue 1828, p18
Reports on research by scientists at the National Cancer Institute that have begun small-scale studies on the immune systems of people who have been repeatedly exposed to HIV without apparently becoming infected. Men studied; Findings; Conclusion; Discovery of the crystal structure of the HIV's...
- Breaking the news: `You've been exposed to HIV'
Brown, Phyllida // Glamour; Aug97, Vol. 95 Issue 8, p118
Presents information on an East Saint Louis, Illinois man who transmitted the Human immunodeficiency virus (HIV) to more than 100 women. Efforts of the Centers for Disease Control and Prevention; Role of Annie C. Howerton-Privott of the Centers for Disease Control and Prevention.
- Report shows HIV/AIDS in slow decline.
Brown, Phyllida // Australian Nursing Journal; Sep97, Vol. 5 Issue 3, p10
Predicts a slow and steady decline of human immunodeficiency virus (HIV) or acquired immunodeficiency virus cases in Australia. Estimated HIV cases; Decrease of HIV transmission among homosexually active men.
- `Other' virus lying in wait.
Beradelli, Phil // Insight on the News; 10/06/97, Vol. 13 Issue 37, p42
Focuses on the T-cell lymphotropic virus (HTLV). Details on what the virus causes; Where the virus can be found; Background information on the virus; How the virus can be caught; Comparison of HTLV to the human immunodeficiency virus (HIV); Comments from Thomas Waldmann, chief of the National...
- Genetic organization of a chimpanzee lentivirus related to HIV-1.
Huet, T.; Cheynier, R. // Nature; 5/24/1990, Vol. 345 Issue 6273, p356
Describes the molecular cloning and sequencing of an infectious proviral clone of SIVCPZ lentivirus. Findings indicate that there is a larger pool of simian lentiviruses than previously suspected and revives the debate as to the origins of HIV-1.
- Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives.
Pauwels, R.; Andries, K. // Nature; 2/1/1990, Vol. 343 Issue 6257, p470
Investigates new anti-HIV (human immunodeficiency virus) compounds with acceptable pharmacology. Methods; Results; Discussion.
- Processing of the precursor of NF-kB by the HIV-1 protease during acute infection.
Riviere, Y.; Blank, V. // Nature; 4/18/1991, Vol. 350 Issue 6319, p625
Demonstrates that the human immunodeficiency virus type 1 (HIV-1) protease can process 105K precursor and increases in levels of active nuclear NF-kB complex. Experimental methods; Results; Discussion.
- Danger at the border.
Riviere, Y.; Blank, V. // Advocate;
Reports that four more potent strains of human immunodeficiency virus (HIV) that millions have already contracted in Asia and Africa will soon come to the United States. Warning aired in a Boston conference by Harvard AIDS Institute chairman Max Essex; Identification of the strains and modes of...
- Living proof: Thinking positive.
Riviere, Y.; Blank, V. // Seventeen; Dec92, Vol. 51 Issue 12, p48
Profiles people who are HIV-positive, their positive attitudes and how they are dealing with the diagnosis. Vanessa Clark, 25; Mary Hanerfeld; David Haney, 34; More.
- At the foot of Buddha.
Riviere, Y.; Blank, V. // New Internationalist; Oct96, Issue 284, p4
Presents captions which focuses on the caring role played by monks in one of Thailand's largest acquired immunodeficiency syndrome (AIDS) hospice. How many patients are housed at the hospice; Information on some of persons afflicted with AIDS; Examination of care given to patients.
- A plague ignored.
Zimmerman, Carlota // Russian Life; May97, Vol. 40 Issue 5, p6
Reports that as of March 1997, there were 3,327 officially reported cases of HIV-infection in Russia. Information on Gennady Roshchupkin, an AIDS activist and an AIDS victim; Activities of Russians which are putting them at danger of contracting the disease; When the first case of HIV was...
- Tanzania plans to establish a special fund for HIV/AIDS.
Zimmerman, Carlota // African Business News; 4/26/2013, p19
The article reports on the plan of Tanzania to create a special fund for human immunodeficiency virus (HIV)/acquired immune deficiency syndrome (AIDS) that will lead to a decline in its dependence on external donors by half.
Zimmerman, Carlota // Time International (South Pacific Edition); 03/04/96, Issue 10, p14
Reports on the controversies over the use of human immunodeficiency virus (HIV) tainted blood in Tokyo, Japan. Reference to a file which was revealed by Health and Welfare Minister, Naoto Kan; Number of Japanese who were infected with HIV after the use of the HIV-infected blood; Comments from...
- `Dad, I'm HIV positive.'
Schoch, Russell // Newsweek; 8/17/1992, Vol. 120 Issue 7, p9
Opinion. Examines the author's reaction to the news that his hemophiliac son had contracted the HIV virus. Why he and his son strongly support the effort to re-examine the hypothesis that HIV causes AIDS; Determination to help his son live a life that is as long and as full as it can be.
- HIV funds dry up.
Schoch, Russell // New Scientist; 1/11/92, Vol. 133 Issue 1803, p16
Reports that health officials in cities across the United States fear they may run out of funds for HIV testing within weeks. Demand for testing which rose after Earvin `Magic' Johnson announced he was infected; Cities affected; Number of calls daily at the CDC's National AIDS Hotline.
- Magh Mela Festival at Sangam.
Schoch, Russell // India -- West; 1/8/2010, Vol. 35 Issue 7, pA41
The article offers news briefs in India in 2010 including three cases of HIV everyday recorded at Goa, the incrimination of Kerala Communist Party of India-Marxist secretary Pinrayi Vijayan as an accuse din a graft case associating to the granting of contract and the fear of residents at...
- The sugarcoated virus.
Gadsby, P. // Discover; Jul88 Supplement, Vol. 9 Issue 7, p30
Examines the AIDS virus' outer membrane. How the glycoproteins confuse the body's immune system infect cells and pose new problems for developing a vaccine.
- Diversity equals death.
Nowak, R. // Discover; May92, Vol. 13 Issue 5, p16
Presents a new theory from two mathematical biologists, Robert May and Martin Nowak of Oxford University, who say that the human immunodeficiency virus (HIV) causes AIDS by quickly diversifying into more strains than the body's immune system can handle. Analysis of HIV-infected immune system as...